Interleukin 1 receptor antagonist gene polymorphism in women with vulvar vestibulitis

American Journal of Obstetrics and Gynecology

Volumn 182, Issue 2, 2000, Pages 283-285

  Jeremias, Jan ^b   Ledger, William J ^b   Witkin, Steven S ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b NONE

Author keywords

Gene polymorphism; Interleukin 1 receptor antagonist; Vulvar vestibulitis

Indexed keywords

INTERLEUKIN 1 RECEPTOR BLOCKING AGENT;

ALLELE; ARTICLE; DISEASE PREDISPOSITION; FEMALE; GENETIC POLYMORPHISM; HOMOZYGOSITY; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; VULVAR VESTIBULITIS; WART VIRUS;

EID: 0005870344     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9378(00)70212-2     Document Type: Article

References (19)

1. 1. Pyke RE, Wilkinsov EJ, Friedrich EG Jr. Crotier BP. The histopathology of vulvar vestibulitis syndrome. Int J Gynecol Pathol 1988;7:249-53.
2. 2. Bergeron S, Binik YM, Khalife S, Pagidas K. Vulvar vestibulitis syndrome: a crilical review. Clin J Pain 1997;13:27-42.
3. 3. Chadha S, Gianotten WL, Drogendijk AC, Weijmar A, Schultz WC, Blindermen LA, et al. Histopathologic features of vulvar vestibulitis. Int J Gynecol Pathol 1998;17:7-11.
4. 4. Bornstein J, Shapiro S, Rahat M, Goldshmid N, Goldik Z, Abramovici H, et al. Polymerase chain reaction search for viral etiology of vulvar vestibulitis syndrome. Am J Obstet Gynecol 1996;175:139-44.
5. 5. Ledger WJ, Kessler A, Leonard GH, Witkin SS. Vulvar vestibulitis: a complex clinical entity. Infect Dis Obstet Gynecol 1996;4:269-75.
6. 6. Glazer HI, Rodke G, Swencionis C, Hertz R, Young AW. Treatment of vulvar vestibulitis syndrome with electromyographic biofeedback of pelvic floor musculature. J Reprod Med 1991;46:283-90.
7. 7. Foster DC, Hasday JD. Elevated tissue levels of interleukin-1 beta and tumor necrosis factor-alpha in vulvar vestibulitis. Obstet Gynecol 1997;89:291-6.
8. 8. Nemetz A, Kope A, Molnar T, et al. Significant differences in the interleukin-1β and interleukin-1 receptor antagonist gene polymorphisms in a Hungarian population with inflammatory bowel disease. Scand J Gastroenterol 1999;34:175-9.
9. 9. Bioque G, Crusiuis JB, Koutroubakis I, et al. Allelic polymorphism in IL-1β and IL-1 receptor antagonist (IL-1RA) genes in inflammatory bowel disease. Clin Exp Immunol 1995;102:379-83.
10. 10. Dinarello CA. Biology of interleukin-1. FASEB J 1998;2:108-15.
11. 11. Schrijer HM, Crusius JB, Uitdehaag BM, et al. Association of interleukin-1β and interleukin-1 receptor antagonist genes with disease severity in MS. Neurology 1999;52:595-9.
12. 12. Steinkasserer A, Spurr NK, Cox S, Jeggo P, Sim RB. The human 1L-1 receptor antagonist gene maps to chromosome 2q14-21 in the region of the IL-1 loci. Genomics 1992;13:654-7.
13. 13. Tarlow JK, Blakemore AI, Lennard A, et al. Polymorphism in human IL-1 receptor antagonist gene intron 2 is caused by variable numbers of an 86-bp tandem repeat. Hum Genet 1993;91:403-4.
14. 14. Santtila S, Savinainen K, Hurme M. Presence of the IL-1RA allele 2 is associated with enhanced IL-1β production in vitro. Scand J Immunol 1998;47:195-8.
15. 15. Strauss JF. Unravelling ihe genetics of complex disorders of reproduction. In: Coutinho EM, Spinola P, editors. Reproductive medicine: a millennium review. New York: The Parthenon Publishing Group; 1999. p. 284-7.
16. 16. Tarlow JK, Clay FE, Cork MJ, et al. Severity of alopecia areata is associated with a polymorphism in the interleukin-1 receptor antagonist gene. J Invest Dermatol 1994;103:387-90.
17. 17. Mansfield JC, Holden H, Tarlow JK, et al. Novel genetic association between ulcerative colitis and the anti-inflammatory cytokine interleukin-1 receptor antagonist. Gastroenterology 1994;106:637-42.
18. 18. Bioque G, Bouma G, Crusius JBA, et al. Evidence for genetic heterogeneity in IBD. I. The interleukin-1 receptor antagonist in the predisposition to suffer from ulcerative colitis. Eur J Gastroenterol Hepatol 1996;8:105-10.
19. 19. Heresbach D, Alizadeh M, Dabadie A, et al. Significance of interleukin-1beta and interleukin-1 receptor antagonist genetic polymorphism in inflammatory bowel diseases. Am J Gastroenterol 1997;92:1164-9.